Update on the role of triglycerides as a risk factor for coronary heart disease.

被引:11
|
作者
Miller M. [1 ]
Cosgrove B. [1 ]
Havas S. [1 ]
机构
[1] Department of Medicine, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, 21201, MD
关键词
Fenofibrate; Coronary Heart Disease Risk Factor; Summary Relative Risk; Receive Hormone Replacement Therapy; Bezafibrate Infarction Prevention;
D O I
10.1007/s11883-002-0044-0
中图分类号
学科分类号
摘要
Elevated triglyceride levels represent an independent risk factor for coronary heart disease, and recently the National Cholesterol Education Program revised the acceptable level of fasting triglycerides from less than 200 mg/dL to below 150 mg/dL. However, a sizeable proportion of people in Western societies has persistently elevated triglyceride levels. Fortunately, hygienic and pharmacologic measures can have a considerable impact on reducing triglyceride levels. However, an important yet unanswered question is whether decreasing triglycerides beyond low-density lipoprotein cholesterol lowering contributes significantly to additional coronary heart disease event reduction.
引用
收藏
页码:414 / 418
页数:4
相关论文
共 50 条
  • [21] Evaluation of Chevon on risk factors for coronary heart disease.
    Burnett, D. D.
    White, S. B.
    Corley, M. M.
    Corley, R. N., III
    POULTRY SCIENCE, 2007, 86 : 434 - 434
  • [22] SERUM TRIGLYCERIDES, TO BE OR NOT TO BE A RISK FACTOR FOR ISCHEMIC-HEART-DISEASE
    CARLSON, LA
    BOTTIGER, LE
    ATHEROSCLEROSIS, 1981, 39 (03) : 287 - 291
  • [23] Treatment of hyperlipidaemia as a risk factor for coronary heart disease: the role of fibrates
    Linssen, R
    HOSPITAL MEDICINE, 1999, 60 (04): : 298 - 301
  • [24] TRIGLYCERIDES AND CORONARY HEART-DISEASE
    HEYDEN, S
    HAMES, CG
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (18): : 1061 - 1061
  • [25] Risk Scores for Prediction of Coronary Heart Disease: An Update
    Wilson, Peter W. F.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2009, 38 (01) : 33 - +
  • [26] Depression as a controlled risk factor for heart failure progression in patients with coronary heart disease. The influence of patients education
    Zueva, I.
    Zueva, Irina B.
    Borzova, Maria A.
    Novoselova, Larisa S.
    Brodskaya, Inna S.
    EUROPEAN HEART JOURNAL, 2006, 27 : 47 - 47
  • [27] Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?
    Reiner, Zeljko
    CARDIOLOGY, 2015, 131 (04) : 225 - 227
  • [28] Genetic risk, physical fitness and incident coronary heart disease.
    Kim, Youngwon
    Lotta, Luca
    Sharp, Stephen
    Wijndaele, Katrien
    Day, Felix
    Perry, John
    Wareham, Nick
    Brage, Soren
    JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2018, 15 (10): : S50 - S51
  • [29] Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.
    Cannon, Christopher P.
    Shah, Sukrut
    Dansky, Hayes M.
    Davidson, Michael
    Brinton, Eliot A.
    Gotto, Antonio M., Jr.
    Stepanavage, Michael
    Liu, Sherry Xueyu
    Gibbons, Patrice
    Ashraf, Tanya B.
    Zafarino, Jennifer
    Mitchel, Yale
    Barter, Philip
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (25): : 2406 - 2415
  • [30] Is depression a risk factor for coronary heart disease?
    Pickering, TG
    Davidson, K
    Shimbo, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (02) : 472 - 473